New private venture tackles the riddle of Long Covid—and aims to test treatments quickly
Initiative focuses first on hypothesis that coronavirus lingers in patients
I took an international trip with my frozen eggs to learn about the fertility industry
More people like me are using the services of specialized couriers to access reproductive care that isn’t available or affordable at home.
ESMO: BioNTech's CAR-T response rate falls in fresh cut of early-phase data
Verily raises $1bn to push ahead with precision health plans
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma
Forge Biologics continues its hot streak with $90M round to boost gene therapy manufacturing services
Akero hits endpoints in midphase NASH trial, linking candidate to improvements in fibrosis
Europe’s Drought Might Force Acceptance of Gene-Edited Crops
For decades, the EU has had some of the tightest restrictions on genetically altered agriculture. That could be about to change.
Ori Biotech taps MD Anderson, National Resilience joint venture to put its automated cell & gene therapy manufacturing tech to the test
Treatment of Genetic Diseases With CRISPR Genome Editing
Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches
Much Anticipated Alzheimer Disease Prevention Trial Finds No Clinical Benefit From Drug Targeting Amyloid; Highlights Need to Consider Other Approaches | Dementia and Cognitive Impairment | JAMA | JAMA Network
SparingVision raises €75m for eye disease gene therapies
Starry syndicate powers $165M bet on in vivo CAR-T therapies, enabling Penn spinout Capstan to set sail
Prostate cancer – Nature Outlook
There is no malignancy more common for a man in a high-income country than prostate cancer.
Could immunotherapy finally breakthrough in prostate cancer?
Despite success against other cancers, prostate tumours have so far resisted treatment with immunotherapy. But some researchers are persisting with the approach.
‘Practice Changing’ Data Show Benefits of Cell Therapy in Advanced Melanoma
One of Long COVID’s Worst Symptoms Is Also Its Most Misunderstood
Brain fog isn’t like a hangover or depression. It’s a disorder of executive function that makes basic cognitive tasks absurdly hard.
Borrowing CAR-T tool from cancer therapy, lupus patients go into remission
Scientists are using AI to dream up revolutionary new proteins
Huge advances in artificial intelligence mean researchers can design completely original molecules in seconds instead of months.
Intellia's gene editing therapies both post early successes as evidence grows for CRISPR potential